［1］Carballo CB，Nakagawa Y，Sekiya I，et al.Basic science of articular cartilage［J］.Clin Sports Med，2017，36(3)：413-425.
［2］Dean CS，Chahla J，Serra CR，et al.Fresh osteochondral allograft transplantation for treatment of articular cartilage defects of the knee［J］.Arthrosc Tech，2016，5(1)：e157-e161.
［3］Langer F，Gross AE.Immunogenicity of allograft articular cartilage［J］.J Bone Joint Surg (Am)，1974，56(2)：297-304.
［4］Gross AE，Silverstein EA，Falk J，et al.The allotransplantation of partial joints in the treatment of osteoarthritis of the knee［J］.Clin Orthop Relat Res，1975(108)：7-14.
［5］Shasha N，Krywulak S，Backstein D，et al.Long-term follow-up of fresh tibial osteochondral allografts for failed tibial plateau fractures［J］.J Bone Joint Surg (Am)，2003，85(Suppl 2)：33-39.
［6］Jamali AA，Emmerson BC，Chung C，et al.Fresh osteochondral allografts：results in the patellofemoral joint［J］.Clin Orthop Relat Res，2005(437)：176-185.
［7］Flynn JM，Springfield DS，Mankin HJ.Osteoarticular allografts to treat distal femoral osteonecrosis［J］.Clin Orthop Relat Res，1994(303)：38-43.
［8］Garrett JC.Fresh osteochondral allografts for treatment of articular defects in osteochondritis dissecans of the lateral femoral condyle in adults［J］.Clin Orthop Relat Res，1994(303)：33-37.
［9］Emmerson BC，Grtz S，Jamali AA，et al.Fresh osteochondral allografting in the treatment of osteochondritis dissecans of the femoral condyle［J］.Am J Sports Med，2007，35(6)：907-914.
［10］Mologne TS，Bugbee WD，Kaushal S，et al.Osteochondral allografts for large oval defects of the medial femoral condyle：A Comparison of single lateral versus medial femoral condyle oval grafts versus 2 overlapping circular grafts［J］.Am J Sports Med，2023，51(2)：379-388.
［11］Garrity JT，Stoker AM，Sims HJ，et al.Improved osteochondral allograft preservation using serum-free media at body temperature［J］.Am J Sports Med，2012，40(11)：2542-2548.
［12］Stoker AM，Stannard JP，Kuroki K，et al.Validation of the missouri osteochondral allograft preservation system for the maintenance of osteochondral allograft quality during prolonged storage［J］.Am J Sports Med，2018，46(1)：58-65.
［13］Sherman SL，Garrity J，Bauer K，et al.Fresh osteochondral allograft transplantation for the knee：Current concepts［J］.J Am Acad Orthop Surg，2014，22(2)：121-133.
［14］De Caro F，Bisicchia S，Amendola A，et al.Large fresh osteochondral allografts of the knee：A systematic clinical and basic science review of the literature［J］.Arthroscopy，2015，31(4)：757-765.
［15］Cook JL，Stannard JP，Stoker AM，et al.Importance of donor chondrocyte viability for osteochondral allografts［J］.Am J Sports Med，2016，44(5)：1260-1268.
［16］Vangsness CJ，Garcia IA，Mills CR，et al.Allograft transplantation in the knee：Tissue regulation，procurement，processing，and sterilization［J］.Am J Sports Med，2003，31(3)：474-481.
［17］Lattermann C，Romine SE.Osteochondral allografts：State of the art［J］.Clin Sports Med，2009，28(2)：285-301.
［18］Ball ST，Amiel D，Williams SK，et al.The effects of storage on fresh human osteochondral allografts［J］.Clin Orthop Relat Res，2004(418)：246-252.
［19］Brockbank KG，Rahn E，Wright GJ，et al.Impact of hypothermia upon chondrocyte viability and cartilage matrix permeability after 1 month of refrigerated storage［J］.Transfus Med Hemother，2011，38(6)：387-392.
［20］Curtiss PJ，Powell AE，Herndon CH.Immunological factors in homogenous-bone transplantation.Ⅱ.The inability of homogenous rabbit bone to induce circulating antibodies in rabbits［J］.J Bone Joint Surg (Am)，1959(41-A)：1482-1488.
［21］Curtiss PJ，Chase SW，Herndon CH.Immunological factors in homogenous-bone transplantation.Ⅱ.Histological studies［J］.J Bone Joint Surg (Am)，1956，38 (2)：324-328.
［22］Curtiss PH，Herndon CH.Immunological factors in homogenous-bone transplantation.I.Serological studies.［J］.J Bone Joint Surg (Am)，1956，38(1)：103-110.
［23］Herndon CH，Chase SW.The fate of massive autogenous and homogenous bone grafts including articular surfaces［J］.Surg Gynecol Obstet，1954，98(3)：273-290.
［24］Volkov M.Allotransplantation of joints［J］.J Bone Joint Surg (Br)，1970，52(1)：49-53.
［25］Ottolenohi CE.Massive osteo and osteo-articular bone grafts technic and results of 62 cases［J］.Clin Orthop Relat Res，1972(87)：156-164.
［26］Parrish FF.Allograft replacement of all or part of the end of a long bone following excision of a tumor［J］.J Bone Joint Surg (Am)，1973，55(1)：1-22.
［27］Gross AE，McKee NH，Pritzker KP，et al.Reconstruction of skeletal deficits at the knee.A comprehensive osteochondral transplant program［J］.Clin Orthop Relat Res，1983(174)：96-106.
［28］Malinin TI，Wagner JL，Pita JC，et al.Hypothermic storage and cryopreservation of cartilage.An experimental study［J］.Clin Orthop Relat Res，1985(197)：15-26.
［29］Enneking WF，Mindell ER.Observations on massive retrieved human allografts［J］.J Bone Joint Surg (Am)，1991，73(8)：1123-1142.
［30］Ohlendorf C，Tomford WW，Mankin HJ.Chondrocyte survival in cryopreserved osteochondral articular cartilage［J］.J Orthop Res，1996，14(3)：413-416.
［31］Enneking WF，Campanacci DA.Retrieved human allografts：A clinicopathological study［J］.J Bone Joint Surg (Am)，2001，83(7)：971-986.
［32］Muldrew K，Novak K，Studholme C，et al.Transplantation of articular cartilage following a step-cooling cryopreservation protocol［J］.Cryobiology，2001，43(3)：260-267.
［33］Acosta CA，Izal I，Ripalda P，et al.Cell viability and protein composition in cryopreserved cartilage［J］.Clin Orthop Relat Res，2007(460)：234-239.
［34］Laouar L，Fishbein K，McGann LE，et al.Cryopreservation of porcine articular cartilage：MRI and biochemical results after different freezing protocols［J］.Cryobiology，2007，54(1)：36-43.
［35］Judas F，Rosa S，Teixeira L，et al.Chondrocyte viability in fresh and frozen large human osteochondral allografts：effect of cryoprotective agents［J］.Transplant Proc，2007，39(8)：2531-2534.
［36］Rosa SC，Gonalves J，Judas F，et al.Assessment of strategies to increase chondrocyte viability in cryopreserved human osteochondral allografts：evaluation of the glycosylated hydroquinone，arbutin［J］.Osteoarthritis Cartilage，2009，17(12)：1657-1661.
［37］Brockbank KG，Chen ZZ，Song YC.Vitrification of porcine articular cartilage［J］.Cryobiology，2010，60(2)：217-221.
［38］Elmoazzen HY，Poovadan A，Law GK，et al.Dimethyl sulfoxide toxicity kinetics in intact articular cartilage［J］.Cell Tissue Bank，2007，8(2)：125-133.
［39］Jomha NM，Weiss AD，Fraser FJ，et al.Cryoprotectant agent toxicity in porcine articular chondrocytes［J］.Cryobiology，2010，61(3)：297-302.
［40］Fahy GM，Wowk B，Wu J，et al.Improved vitrification solutions based on the predictability of vitrification solution toxicity［J］.Cryobiology，2004，48(1)：22-35.
［41］Almansoori KA，Prasad V，Forbes JF，et al.Cryoprotective agent toxicity interactions in human articular chondrocytes［J］.Cryobiology，2012，64(3)：185-191.
［42］Zhang SZ，Yu XY，Chen GM.Permeation of dimethyl sulfoxide into articular cartilage at subzero temperatures［J］.J Zhejiang Univ Sci B，2012，13(3)：213-220.
［43］Shardt N，Al-Abbasi KK，Yu H，et al.Cryoprotectant kinetic analysis of a human articular cartilage vitrification protocol［J］.Cryobiology，2016，73(1)：80-92.
［44］Shardt N，Chen Z，Yuan SC，et al.Using engineering models to shorten cryoprotectant loading time for the vitrification of articular cartilage［J］.Cryobiology，2020(92)：180-188.
［45］Stadnyk M，Sevick JL，Wu K，et al.The effect of cryoprotectant vehicle solution on cartilage cell viability following vitrification［J］.Cell Tissue Bank，2022，23(1)：31-41.
［46］Wu K，Laouar L，Elliott J，et al.Vitrification of intact porcine femoral condyle allografts using an optimized approach［J］.Cartilage，2021，13(2 suppl)：1688S-1699S.
［47］He J，Wine I，Wu K，et al.Effect of vitrification on mechanical properties of porcine articular cartilage［J］.Proc Inst Mech Eng H，2022，236(10)：1521-1527.
［48］Ead M，Wu K，Jar C，et al.Mechanical properties of fresh，frozen and vitrified articular cartilage［J］.Ann Biomed Eng，2023，51(9)：2001-2012.
［49］Beaver RJ，Mahomed M，Backstein D，et al.Fresh osteochondral allografts for post-traumatic defects in the knee.A survivorship analysis［J］.J Bone Joint Surg (Br)，1992，74(1)：105-110.
［50］Ranawat AS，Vidal AF，Chen CT，et al.Material properties of fresh cold-stored allografts for osteochondral defects at 1 year［J］.Clin Orthop Relat Res，2008，466(8)：1826-1836.
［51］Pallante AL，Bae WC，Chen AC，et al.Chondrocyte viability is higher after prolonged storage at 37 degrees C than at 4 degrees C for osteochondral grafts［J］.Am J Sports Med，2009，37 Suppl 1(Suppl 1)：24S-32S.
［52］McCarty WJ，Pallante AL，Rone RJ，et al.The proteoglycan metabolism of articular cartilage in joint-scale culture［J］.Tissue Eng Part A，2010，16(5)：1717-1727.
［53］Stoker A，Garrity JT，Hung CT，et al.Improved preservation of fresh osteochondral allografts for clinical use［J］.J Knee Surg，2012，25(2)：117-125.
［54］Cook JL，Stoker AM，Stannard JP，et al.A novel system improves preservation of osteochondral allografts［J］.Clin Orthop Relat Res，2014，472(11)：3404-3414.
［55］Nover AB，Stefani RM，Lee SL，et al.Long-term storage and preservation of tissue engineered articular cartilage［J］.J Orthop Res，2016，34(1)：141-148.
［56］Stoker AM，Caldwell KM，Stannard JP，et al.Metabolic responses of osteochondral allografts to re-warming［J］.J Orthop Res，2019，37(7)：1530-1536.
［57］Denbeigh JM，Hevesi M，Paggi CA，et al.Modernizing storage conditions for fresh osteochondral allografts by optimizing viability at physiologic temperatures and conditions［J］.Cartilage，2021，13(1 suppl)：280S-292S.
［58］Pylawka TK，Virdi AS，Cole BJ，et al.Reversal of suppressed metabolism in prolonged cold preserved cartilage［J］.J Orthop Res，2008，26(2)：247-254.
［59］Onuma K，Urabe K，Naruse K，et al.Cold preservation of rat osteochondral tissues in two types of solid organ preservation solution，culture medium and saline［J］.Cell Tissue Bank，2009，10(1)：1-9.
［60］Bae JY，Matsumura K，Wakitani S，et al.Beneficial storage effects of epigallocatechin-3-o-gallate on the articular cartilage of rabbit osteochondral allografts［J］.Cell Transplant，2009，18(5)：505-512.
［61］Bae JY，Han DW，Wakitani S，et al.Biological and biomechanical evaluations of osteochondral allografts preserved in cold storage solution containing epigallocatechin gallate［J］.Cell Transplant，2010，19(6)：681-689.
［62］Linn MS，Chase DC，Healey RM，et al.Etanercept enhances preservation of osteochondral allograft viability［J］.Am J Sports Med，2011，39(7)：1494-1499.
［63］Calvo R，Espinosa M，Figueroa D，et al.Assessment of cell viability of fresh osteochondral allografts in N-acetylcysteine-enriched medium［J］.Cartilage，2020，11(1)：117-121.
［64］Dontchos BN，Coyle CH，Izzo NJ，et al.Optimizing CO2 normalizes pH and enhances chondrocyte viability during cold storage［J］.J Orthop Res，2008，26(5)：643-650.
［65］Han Y，Qu P，Zhang K，et al.Storage solution containing hydrogen improves the preservation effect of osteochondral allograft［J］.Cell Tissue Bank，2019，20(2)：201-208.
［66］Teng MS，Yuen AS，Kim HT.Enhancing osteochondral allograft viability：Effects of storage media composition［J］.Clin Orthop Relat Res，2008，466(8)：1804-1809.
［67］Bian L，Lima EG，Angione SL，et al.Mechanical and biochemical characterization of cartilage explants in serum-free culture［J］.J Biomech，2008，41(6)：1153-1159.
［68］Onuma K，Urabe K，Naruse K，et al.Allogenic serum improves cold preservation of osteochondral allografts［J］.Clin Orthop Relat Res，2012，470(10)：2905-2914.
［69］Wright GJ，Brockbank KG，Rahn E，et al.Impact of storage solution formulation during refrigerated storage upon chondrocyte viability and cartilage matrix［J］.Cells Tissues Organs，2014，199(1)：51-58.
［70］Hangody LR，GálT，Szücs A，et al.Osteochondral allograft transplantation from a living donor［J］.Arthroscopy，2012，28(8)：1180-1183.
［71］Hevesi M，Denbeigh JM，Paggi CA，et al.Fresh Osteochondral allograft transplantation in the knee：A viability and histologic analysis for optimizing graft viability and expanding existing standard processed graft resources using a living donor cartilage program［J］.Cartilage，2021，13(1_suppl)：948S-956S.
［72］Campbell J，Filardo G，Bruce B，et al.Salvage of contaminated osteochondral allografts：The effects of chlorhexidine on human articular chondrocyte viability［J］.Am J Sports Med，2014，42(4)：973-978.
［73］Rorick CB，Mitchell JA，Bledsoe RH，et al.Cryopreserved，thin，laser-etched osteochondral allograft maintains the functional components of articular cartilage after 2 years of storage［J］.J Orthop Surg Res，2020，15(1)：521.
晋公网安备 14010702070875号